Skip to content
    ECVT
    Earnings call· Jun 2026(Q2 FY26)

    Ecovyst Q2 FY26 earnings call ECVT

    Aug 5, 2026 Source

    Executive summary

    Ecovyst Q2 FY26 — Strong Performance Driven by Volume Growth and Strategic Acquisition

    Ecovyst delivered strong second-quarter results, driven by robust volume growth in both regenerated and virgin sulfuric acid, favorable pricing, and the strategic acquisition of Calabrian. The company successfully integrated Calabrian, which is expected to contribute positively to the second half, while maintaining a healthy balance sheet and progressing with Gulf Coast expansion projects. Management anticipates sulfur prices to moderate, balancing end-market demand and cost pressures.

    Highlights

    4

    • Adjusted EBITDA of $53 million, up 27% year-over-year, solidly within guidance range.

    • Virgin sulfuric acid volume increased on a double-digit percentage basis compared to the year-ago quarter.

    • Successfully closed the acquisition of the Calabrian sulfur dioxide business on June 30, which is accretive from day one.

    • Ended the quarter with a net debt leverage ratio of 2x, at the low end of the 2x-2.5x target range, after funding Calabrian.

    Concerns

    3

    • Sulfur prices continued to increase, with the full-year pass-through effect on sales now expected to be approximately $220 million higher compared to the prior year (up from $155 million previously expected).

    • Potential for temporary demand impact from destocking if customers begin to anticipate lower sulfur prices.

    • Higher turnaround costs are expected in the third and fourth quarters of 2026 compared to the prior year.

    Guidance & targets

    14
    CategoryTargetConfidence
    Full Year 2026 Sales
    $1.02B - $1.06B
    high materiality
    High
    Full Year 2026 Adjusted EBITDA (Legacy Business)
    $185M - $195M
    high materiality
    High
    Full Year 2026 Adjusted EBITDA (Calabrian Contribution)
    $10M - $12M
    medium materiality
    High
    Full Year 2026 Adjusted EBITDA (Total)
    $195M - $207M
    high materiality
    High
    Full Year 2026 Adjusted Free Cash Flow
    $45M - $55M
    high materiality
    High
    Full Year 2026 Interest Expense
    $18M - $22M
    medium materiality
    High
    Full Year 2026 Capital Expenditures
    $85M - $95M
    high materiality
    High
    Full Year 2026 Depreciation and Amortization
    $80M - $84M
    medium materiality
    High
    Full Year 2026 Effective Tax Rate
    mid-20% range
    medium materiality
    High
    Full Year 2026 Adjusted Net Income
    $65M - $85M
    high materiality
    High
    Full Year 2026 Adjusted Diluted Net Income Per Share
    $0.58 - $0.72
    high materiality
    High
    Q3 2026 Adjusted EBITDA (including Calabrian)
    $54M - $59M
    medium materiality
    High
    Q4 2026 Adjusted EBITDA (including Calabrian)
    $48M - $55M
    medium materiality
    High
    Full Year 2026 Sulfur Pass-Through Effect on Sales
    approximately $220M higher
    high materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Regenerated Sulfuric Acid
    Sales volume growth was driven by high refinery utilization and favorable alkylate economics. Expected to see higher volumes in the second half of the year with lower unplanned customer downtime.
    Sales Volume: growthAlkylates Economics: favorableRefinery Utilization: high
    		————
    Virgin Sulfuric Acid
    Volume increased on a double-digit percentage basis compared to the year-ago quarter, benefiting from positive demand and the contribution from the Waggaman acquisition. Continued demand growth is seen in the mining sector, particularly for copper expansion projects. Sales into nylon end-use are expected to be relatively flat for 2026. Second half volumes are expected to be lower than prior year due to fewer spot opportunities and turnarounds.
    Sales Volume: double-digit percentage increase YoYWaggaman Contribution: positiveMining Demand: continued growthNylon End-Use Demand: relatively flat
    		—double-digit percentage increase——

    Operational metrics

    20
    Adjusted EBITDA
    $53Mup 27% YoY
    Q2 FY26

    Solidly within guidance range.

    Net Debt Leverage Ratio
    2xup from 1.2x at March 31
    Q2 FY26 end

    At the low end of the target range, reflecting full acquisition debt for Calabrian against none of its trailing 12-month EBITDA.

    Available Liquidity
    $176M
    Q2 FY26 end

    Total available liquidity at quarter end.

    Sulfur Pass-Through Effect on Sales
    $55M
    Q2 FY26

    Generally has no material impact on adjusted EBITDA.

    Sales Growth (ex-sulfur pass-through)
    nearly 11%
    Q2 FY26

    Reflecting higher regenerated and virgin sulfuric acid volume and favorable contractual pricing.

    Price and Variable Cost Contribution to EBITDA
    $9M
    Q2 FY26

    Part of the adjusted EBITDA bridge, showing a continued positive price-to-cost ratio.

    Sales Volume Contribution to EBITDA
    nearly $7M
    Q2 FY26

    Part of the adjusted EBITDA bridge, partially offset by higher fixed manufacturing costs.

    Stock Repurchases
    $83M
    past 15 months

    Part of capital allocation strategy.

    Debt Reduction
    $472M
    past 15 months

    Part of capital allocation strategy.

    Bolt-on Acquisitions (Aggregate)
    $224M
    past 15 months

    Aggregate value for Waggaman and Calabrian acquisitions.

    Calabrian Acquisition Multiple (Pre-Synergy)
    8x
    acquisition

    Multiple at which the Calabrian business was purchased.

    Calabrian Acquisition Multiple (Post-Synergy)
    around 7x
    post-synergy

    Expected multiple after synergies are implemented.

    Calabrian EBITDA Margin
    slightly highervs. legacy business
    ongoing

    Contributes to the positive accretive nature of the acquisition.

    Calabrian Business Size
    roughly 10%of overall business
    ongoing

    Represents a significant, positive accretive acquisition.

    Turnaround Costs
    highervs. prior year
    Q3 & Q4 FY26

    Expected to be higher in Q3 and Q4, with one Q4 turnaround shifted to early 2027.

    Sulfur Price Trend
    plateauing domestically, moderate decreases possible
    H2 FY26

    Management believes prices may have reached a plateau and could begin to decrease later this year, but not a large drop.

    Refinery Utilization
    remain high
    H2 FY26

    Contributes to growth in sales volume for regenerated sulfuric acid.

    Alkylates Economics
    remain favorable
    H2 FY26

    Contributes to growth in sales volume for regenerated sulfuric acid.

    Mining Demand for Sulfur
    strong
    ongoing

    Driven by copper expansion projects tied to structural electrification.

    Nylon End-Use Demand
    relatively flat
    FY26

    Outlook for the year remains consistent with prior expectations.

    Industry KPIs

    2
    MetricValueDetails
    Volume vs price splitnearly 11%%
    Productivity cost savings program$3M-$4MUSD

    Deals & partnerships

    2
    CalabrianAcquisition of sulfur dioxide and related derivatives business$100M (debt funding)

    Closed on June 30, 2026. Broadens portfolio and deepens position in end uses, particularly mining. Funded through a $100 million add-on to term loan.

    WaggamanAcquisition of incremental sulfuric acid capacity

    Acquired in May 2025, added capital-efficient incremental capacity sited in the Gulf Coast network.

    Capital programs

    1
    Gulf Coast storage and logistics network expansionunderway
    Period spend: $20M
    Funding: organic investment
    Start: FY26

    Benefit: enhance ability to serve growing virgin sulfuric acid demand

    Organic investment planned for 2026 to support future growth.

    Risks & headwinds

    4
    Sulfur price increases and potential demand destructionH2 FY26

    Full-year pass-through effect on sales now expected to be approximately $220 million higher compared to the prior year (up from $155 million previously expected).

    Mitigation: Management expects prices to eventually moderate; cautious about temporary demand impact from destocking.

    Higher manufacturing, inflation, and transportation costsQ2 FY26 (ongoing)

    Partially offset adjusted EBITDA growth in Q2 FY26.

    Mitigation: Offset by higher sales volume and favorable net pricing.

    Higher turnaround costsQ3 & Q4 FY26

    Expected to be higher in Q3 and Q4 2026 compared to the prior year.

    Mitigation: One planned Q4 turnaround shifted to early 2027, but Q4 2025 had no turnarounds.

    Lower virgin sulfuric acid spot salesQ3 & Q4 FY26

    Virgin sulfuric acid volume expected to be slightly lower than the year-ago quarter in Q3 and Q4, reflecting fewer expected spot sales.

    Mitigation: 2025 had a high amount of spot opportunities and no turnarounds limiting production.

    What to watch in Q3 FY26

    4

    Calabrian Synergy Realization

    Next quarter / 2027
    CurrentIntegration on plan, leadership retained, demand tracking modeling.
    TargetProgress towards $3M-$4M synergies.

    Why it matters

    Confirms the value creation from the recent acquisition and its impact on the adjusted EBITDA multiple.

    we expect to deliver both cost and revenue synergies, likely in the $3 million to $4 million range.

    Q&A highlights

    7

    How should we think about contract resets for the 90% of business tied to longer-term contracts, given current spot pricing volatility?

    Contracts rolling off later this year are expected to be negotiated at more favorable pricing and terms, assuming current market conditions persist.

    “So it would be our belief and expectation is as those roll off, they should be negotiated as usual at more favorable pricing and terms if everything in terms of the market overall is in the same condition as it is today.”

    asked by Margarita Margulis · answered by Kurt Bitting

    2 min read5 chapters

    Detailed Narrative

    01

    Strategic Acquisitions and Integration

    Ecovyst completed the acquisition of Calabrian, a sulfur dioxide and related derivatives business, on June 30, 2026. This marks the third bolt-on acquisition, following Chem32 in 2021 and Waggaman in 2025, leveraging a playbook of acquiring essential sulfur chemistries adjacent to existing operations. Calabrian is expected to be accretive from day one, broadening the portfolio and deepening positions in existing end-uses, particularly in the mining sector, with anticipated synergies of $3 million to $4 million.

    02

    Sulfur Market Dynamics and Outlook

    Sulfur prices continued to increase in Q2 2026, leading to a higher pass-through effect on sales, now estimated at $220 million higher for the full year compared to the prior year. Management believes domestic sulfur prices may be plateauing at current levels, with potential for moderate decreases later in the year due to fertilizer curtailments offsetting strong mining demand. The company remains cautious about potential temporary demand impacts from destocking if customers anticipate lower prices.

    03

    End-Market Demand Trends

    Demand expectations remain stable across key end-markets. High refinery utilization and favorable alkylate economics are driving strong regenerated sulfuric acid volumes. Virgin sulfuric acid is seeing continued demand growth in the mining sector, particularly from copper expansion projects tied to structural electrification, and sulfur dioxide sales into Canadian gold mines. Demand in the nylon end-use is expected to remain relatively flat for 2026.

    04

    Capital Allocation Strategy

    Over the past 15 months, Ecovyst executed $83 million in stock repurchases, $472 million in debt reduction, and $224 million across two bolt-on acquisitions (Waggaman and Calabrian). The company plans to organically invest approximately $20 million in 2026 for the expansion of its Gulf Coast storage and logistics network. This balanced approach aims to create value for stockholders by weighing organic growth projects, additional bolt-on acquisitions, debt reduction, and stock repurchases.

    05

    Operational Performance Drivers

    Q2 sales were up $74 million, with $55 million attributed to the sulfur pass-through effect. Excluding this, sales grew nearly 11% year-over-year, driven by higher regenerated and virgin sulfuric acid volumes, including contributions from the acquired Waggaman plant, and favorable contractual pricing. Adjusted EBITDA growth was primarily driven by higher sales volume and favorable net pricing, partially offset by increased manufacturing costs, general inflation, and higher transportation costs.

    AI-generated summary of the company’s earnings call. Not investment advice.